Recently, by exome sequencing technology, SETBP1 mutations were found to recur frequently in patients with atypical chronic myeloid leukemia (aCML), a disorder with overlapping clinical features with CML but without the typical Ph1 translocation (34). This evidence concerns the gene SETBP1 and atypical chronic myeloid leukemia, BCR-ABL1 negative.